BioCentury
ARTICLE | Clinical News

Norovirus VLP intramuscular vaccine: Phase IIb started

June 27, 2016 7:00 AM UTC

Takeda began a double-blind, placebo-controlled, U.S. Phase IIb trial to evaluate a single dose of intramuscular TAK-214 in about 3,400 healthy volunteers ages 18-49. ...